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Abstract
The World Health Organization has called for an effort to eliminate Lymphatic Filariasis (LF) around the world. In regions
where the disease is endemic, local production and distribution of medicated salt dosed with diethylcarbamazine (DEC) has
been an effective method for eradicating LF. A partner of the Notre Dame Haiti program, Group SPES in Port-au-Prince, Haiti,
produces a medicated salt called Bon Sel. Coarse salt is pre-washed and sprayed with a solution of DEC citrate and
potassium iodate. Iodine levels are routinely monitored on site by a titrimetric method. However, the factory had no
method for monitoring DEC. Critical analytical issues include 1) determining whether the amount of DEC in each lot of Bon
Sel is within safe and therapeutically useful limits, 2) monitoring variability within and between production runs, and 3)
determining the effect of a common local practice (washing salt before use) on the availability of DEC. This paper describes
a novel titrimetric method for analysis of DEC citrate in medicated salt. The analysis needs no electrical power and requires
only a balance, volumetric glassware, and burets that most salt production programs have on hand for monitoring iodine
levels. The staff of the factory used this analysis method on site to detect underloading of DEC on the salt by their sprayer
and to test a process change that fixed the problem.
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Introduction
The World Health Organization has called for an effort to
eliminate Lymphatic Filariasis (LF) around the world. [1] A
nematode worm (Wuchereria bancrofti) is the cause of 90% of
lymphatic filariasis cases globally. Mosquito bites transmit larval
nematodes (microfilariae) present in the blood stream of infected
persons, and although the adult nematodes are resistant to medical
treatment, human transmission in endemic regions can be stopped
by administering drugs, such as diethylcarbamazine (DEC), that
kill the microfilariae. DEC has had a long history of safe use in
mass drug administration (MDA) LF eradication programs, [2–4]
and so far, W. bancrofti do not appear to have developed resistance
to DEC. [5–6] A course of treatment of 6 mg/kg per day of DEC
citrate for 12 days (daily dose around 300 mg) can significantly
reduce the microfilariae count in an infected person. However, in
regions where the disease is endemic, yearly drug administration to
infected individuals must be continued over the adult worm
lifetime of 4–6 years to eradicate the disease. As an alternative to
pill-based MDA, DEC can be administered to local populations in
the form of medicated cooking salt, with DEC citrate present at
0.2–0.4% w/w, which corresponds to a daily dose of 20–40 mg
DEC citrate. Local production and distribution of medicated salt
fortified with DEC has proved to be a particularly effective
method [7–8] for eradicating LF from endemic regions [9–10].
A partner of the Notre Dame Haiti program, Group SPES in
Port-au-Prince, Haiti, produces a double-supplemented salt called
‘‘Bon Sel’’. [11] Coarse salt is pre-washed and sprayed with a
solution of DEC citrate and potassium iodate. Iodine levels are
routinely monitored on site by a titrimetric method. However, as
of 2010, the factory had no analytical process for monitoring DEC
levels. Critical analytical issues include 1) determining whether the
amount of DEC citrate in each lot of Bon Sel is within safe and
therapeutically useful limits, 2) monitoring variability within and
between production runs, and 3) determining the effect of a
common local practice (washing salt before use) on the availability
of DEC.
The ‘‘gold standard’’ assay for DEC citrate uses high-
performance liquid chromatography (HPLC). [12] Sending
samples out for analysis would impose unwanted costs and
prevent real time analysis of production runs, yet it was impossible
to implement this process at the factory in Haiti, which has no
access to an HPLC or to the supplies and expertise necessary to
maintain one. Color tests and spectrophotometry have been used
for monitoring DEC-medicated salt production, [13–15] although
usually for qualitative monitoring. [16] The facility in Haiti
wanted quantitative information but did not have a spectrometer.
The goal of our group was to develop a back titration assay for
DEC citrate in medicated salt requiring only a balance, volumetric
glassware, and burets, equipment that most iodized salt production
www.plosntds.org 1 February 2011 | Volume 5 | Issue 2 | e1005programs have on hand for monitoring iodine levels, and compare
this method against the benchmark HPLC method.
Materials and Methods
Materials
Samples of untreated NaCl and pharmaceutical grade DEC
citrate (EPICO) were obtained from the Bon Sel plant in Haiti;
pure DEC citrate for HPLC standardization was obtained from
Sigma-Aldrich. The untreated NaCl was a coarse grade produced
by evaporation of seawater and had visible contaminants (dirt,
sand, plant matter).
0.0040 M HCl was prepared by sequential volumetric dilution
of concentrated HCl, and stored in a plastic bottle. Dilute NaOH
solutions are unstable due to reaction with atmospheric CO2.A
0.200 M NaOH stock solution should be prepared (it is stable for
at least 4 weeks) and diluted each day to give the working
0.0100 M NaOH solution. Phenolphthalein indicator solution was
prepared by dissolving 0.5 g of phenolphthalein (Aldrich) in
500 mL of a 50% ethanol:water solution.
Standards: DEC citrate standards (0.05%, 0.125%, 0.25%, and
0.50% w/w of salt) are prepared in the same matrix as the
medicated salt samples. The final solutions are 10% w/v in salt,
thus, to prepare the 0.50% standard, 10 g NaCl and 0.0500 g DEC
citrate are mixed with DI water to give a final volume of 100 ml.
Samples: 5.00 g of medicated salt is dissolved in deionized or
distilled water to a final volume of 50.00 ml with vigorous shaking
(or 10 g/100 ml final volume). A small amount of insoluble
residue is usually present in these samples.
NMR characterization of DEC citrate. DEC citrate in
D2O( ,16 mg/ml, 400 MHz, shifts in ppm vs. TMS): 3.66 (d, 2H,
J=13.2 Hz, piperazine ring proton); 3.42 (d, 2H, J=11.2 Hz,
piperazine ring proton); 3.16 (q, 4H, J=7.2 Hz, N-CH2-CH3),
3.10 (d, 2H, J=13.2 Hz, piperazine ring proton); 3.07 (d, 2H,
J=12.8 Hz, piperazine ring proton); 2.825 (s, 3H, N-CH3); 2.81
(d, 2.2 H, J=19.2 Hz, citrate); 2.67 (d, 2.2H, J=15.6 Hz, citrate);
1.02 (t, 6H, J=7.2 Hz, N-CH2-CH3). The citrate methylene peaks
overlapped the N-CH3 group on the DEC, so this spectrum was
not used to calculate the citrate:DEC stoichiometry. DEC citrate
in DMSO (,16 mg/ml, 400 MHz, shifts in ppm vs. TMS): ,10.5
(br s, 3.17H, R3NH and COOH groups); 3.17(m, 4H, J=4.8 Hz,
piperazine ring proton); 3.11 (q, 4H, J=7.2 Hz, N-CH2-CH3),
2.75(m, 4H, J=4.8 Hz, piperazine ring proton); 2.63 (d, 2.05 H,
J=15.6 Hz, citrate); 2.59 (d, 2.05 H, J=15.2 Hz, citrate); 2.49 (s,
3H, N-CH3, this peak is superposed directly on the DMSO
residual, which is clearly not a normal -CD2H pentet peak); 1.03 (t,
6H, J=7.2 Hz, N-CH2-CH3).
Analysis of DEC citrate by back titration. A 10.00 ml
aliquot of the solution to be analyzed is mixed with 10.00 ml of
0.0100 M NaOH and two drops of phenolphthalein indicator are
added to give a uniform pink color. The solution is titrated to a
clear endpoint with 0.00400 M HCl. The titration should be
carried out in triplicate and the results averaged; the relative
standard deviation of the endpoint volumes for a triplicate trial
RSD~
s
 x x

should be 0.02 or less (typically 0.005).
Analysis of DEC citrate by HPLC. Samples were analyzed
using Mathew’s method [12] on a Shimadzu HPLC. The column
was a 15 cm64.6 mm Luna C8 column (Phenomenex) of 5 mm
particle size with a pre-column fritted filter and a 0.50 ml/min
flow rate; column pressure was about 1200–1400 psi during the
run. The eluent was 9 parts of phosphate buffer (20 mM KH2PO4
adjusted to pH 3.2 with H2SO4 or H3PO4) and 1 part acetonitrile.
The eluent was degassed by vacuum filtration through a 0.4
micron ceramic filter. The detector wavelength was set at 210 nm
and a 20 ml sample loop was used. DEC citrate elutes at
approximately 5.6 minutes.
Samples and standards prepared for back titration are
approximately 10% salinity, with 100 mg/ml NaCl, which would
clog the HPLC column. These samples were diluted 10X and
filtered on a Whatman GD/X 0.45 mm PES syringe filter before
injection onto the HPLC column. Using this sample preparation
protocol, a standard salt sample containing 0.25% w/w DEC,
when prepared for analysis on the HPLC, contains 0.025 mg/ml
DEC citrate and 10 mg/ml NaCl. Standards for HPLC analysis
ranged from 0.005–0.200 mg/ml DEC citrate in 1.0% saline.
Results/Discussion
Chemical basis of the analysis
Standard DEC citrate used in this study (from Sigma-Aldrich)
was identical by NMR (spectra acquired in D2O and d6-DMSO at
400 MHz) to a sample of the DEC citrate (manufactured by
EPICO) that is used at the Bon Sel factory in Haiti. The 1:1
DEC:citrate stoichiometry was confirmed by integration of the
1H-
NMR peaks from the diastereotopic methylene groups on the
citrate and the triplet from the ethyl groups on the DEC (predicted
for a one-to-one stoichiometry of DEC:citrate: 4:6, found 4.2:6.0.)
From the DEC:citrate stoichiometry, each equivalent of DEC
citrate (see structure in Figure 1) contains three acidic protons (two
carboxylic acids and one protonated tertiary amine). These three
Author Summary
As researchers develop more sophisticated technologies,
parts of the world are left behind. The front lines of
fighting many diseases lie in regions where expensive
technology is not feasible. As part of the effort to eradicate
lymphatic filariasis in Haiti, our group’s goal was to design
an assay that would allow a chemist, with basic
equipment, to quantify the levels of diethylcarbamazine
citrate on medicated salt. With access to university
research facilities, we were able to devise and test a
back-titration procedure that can measure the medication
levels with sufficient accuracy and precision. Our method
capitalized on the fact that the medication is acidic. This
characteristic allows us to combine an unknown, medicat-
ed salt sample with a known quantity of base and then
back-titrate with acid to determine diethylcarbamazine
citrate concentration based on the neutralization point.
Developing this protocol has put the power of quality
control into the hands of the Haitian factory producing the
medicated salt. With the ability to better monitor dosing
levels, we have increased the effectiveness of this program
in Haiti. Using modern research facilities to produce
effective, low-tech methods could be a useful approach
for tackling many worldwide medical and environmental
issues.
Figure 1. DEC citrate.
doi:10.1371/journal.pntd.0001005.g001
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the spectrum is acquired in dry DMSO-d6.
Direct titration of DEC citrate with base did not prove
analytically useful. Due to the range of pKa values in the
polyprotic citrate, the end point of the titration was not clear
enough. However, back titration gave a clear endpoint. In the
back titration, a sample of DEC citrate is added to a known excess
of the strong base sodium hydroxide, which reacts completely with
the acidic protons. The remaining hydroxide is titrated with
standard HCl, giving a clear endpoint with the common indicator
phenolphthalein. Bon Sel also contains small amounts of
potassium iodate to supply 40 ppm iodine as a nutritional
supplement. Calibration with DEC citrate standards compensates
for any matrix effects from the salt or interference from the iodate.
It should be noted that this analytical method is not as specific or
generally useful as the HPLC analysis, because any acidic or basic
compound will interfere with the back-titration. Thus, this test
cannot be applied to complex matrices (e.g., determination of
DEC concentration in cooked food or in body fluids).
Titration results
Titration of standard samples gave a linear calibration curve
(Figure 2); the linear least-squares parameters were determined in
Excel using the LINEST function and used to fit unknown
samples. The linear range extends from 0.050% to 0.88% (w/w
DEC citrate in salt), which covers the normal therapeutic range of
DEC in salt (0.1–0.6%, recommended 0.2–0.4%). [17] The
average relative standard deviation (RSD) for the concentration of
known DEC samples at Notre Dame was 1669% by the titration
method, based on triplicate analysis of samples ranging from
0.10% to 0.90% DEC citrate. Samples analyzed in Haiti gave an
average RSD of 3367%. The limit of detection (LOD=3*s/m)
and limit of quantification (LOQ=10*s/m) were calculated; [18]
m is given by the least square fit to the slope of the calibration
curve, and s is the standard deviation of 7 determinations of DEC
concentration for the 0.050% standard sample. The LOD is
0.029% and the LOQ is 0.096% for the titration method.
To compare the titration method and the HPLC method,
multiple standards and unknowns were analyzed with both
methods. Figure 3 shows the results plotted against each other;
the observed slope of the line is 1.014 (for perfect agreement it
would be 1.00). The accuracy of the titration method was
indistinguishable from that of the HPLC method. Applying the
paired t-test [19] for the 10 samples listed in Table 1, the mean
difference between the titration and HPLC results was 20.0018,
the std deviation was 0.016, and tcalc is 0.35. This indicates that the
difference between the titration and HPLC results was not
statistically significant for samples at concentrations of 0.1%–
0.8%, although the precision of the HPLC method was superior
(RSD ,5% for HPLC) and its LOQ was much lower.
Analysis of Bon Sel samples from seven production runs in mid-
2009 showed that all seven production lots ranged from 0.09–
0.13% DEC citrate, with an average of 0.10%60.01%. (Table 2)
This shows that spray coating is an effective technique for
achieving uniform DEC loading on salt at the kg-to-kg and lot-to-
lot level. The loading achieved, while in the therapeutic range
(0.1–0.6% w/w), was lower than the desired loading of 0.2–0.4%
w/w. The loading is a function of the solubility of the DEC citrate
in the spraying solution, the drying rate of the salt, and the salt
feed rate, and could not be improved with the equipment on hand.
However, the group in Haiti tried an experimental run where a
finished batch of salt was dried and fed back into the sprayer; this
double-sprayed salt analyzed at 5067 ppm iodine and 0.2860.7%
Figure 2. DEC citrate standard curve for back titration. DEC
concentration (g/100 g salt) versus endpoint volume of back-titration
are plotted for triplicate standards.
doi:10.1371/journal.pntd.0001005.g002
Figure 3. Comparison of back-titration and HPLC concentra-
tion determinations. Error bars show standard deviation of triplicate
measurements. For low concentration samples, error bars in HPLC
measurement are very small.
doi:10.1371/journal.pntd.0001005.g003
Table 1. Comparison of titration and HPLC analysis of Bon Sel
samples.
Titration average HPLC average Difference
(%DEC citrate w/w) (%DEC citrate w/w)
0.041960.0183 0.059160.0047 20.017
0.061460.0114 0.069660.0011 20.008
0.069260.0096 0.034260.0010 0.035
0.084860.0069 0.097060.0020 20.012
0.084860.0150 0.084660.0022 0.0002
0.125360.0254 0.110560.0005 0.015
0.138160.0183 0.151660.0049 20.014
0.188160.0220 0.194160.0122 20.006
0.321160.0215 0.318560.0092 0.0026
0.883560.0145 0.896560.0456 20.013
doi:10.1371/journal.pntd.0001005.t001
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(double sprayed)).
To monitor heterogeneity within the bags of Bon Sel, three 10 g
grab samples from each of several 1 kg bags of Bon Sel (taken from
different lots) were tested; the levels of DEC citrate varied from
0.08 to 0.15% for samples taken within the same bag of Bon Sel.
This heterogeneity was not due to errors in the titration analysis, as
the results were confirmed by HPLC analysis, which has a much
higher precision. Because the DEC is sprayed onto the salt, which
contains both coarse (low surface area) and fine (high surface area)
crystals, DEC loading is expected to be a function of salt crystal
size. Two lots of Bon Sel from the mid-2009 production runs were
screened to separate particles .4 mm in size from particles
,4 mm in size; in each case, the large crystals had significantly
lower loading of DEC than the small crystals. For example, in one
lot, the large crystals gave a DEC loading of 0.03460.001% while
the small crystals came in at 0.08560.002% (these low loadings
were measured using HPLC to obtain more precise results). The
variation in loading with crystal size appears to be large enough to
account for most of the heterogeneity in the within-lot analyses,
and suggests that more uniform spray coating and higher loadings
would be achieved by crushing the salt before spraying it.
The salt available in Haitian markets is often of low purity, and
many people rinse the salt before using it in cooking. Although
Bon Sel is pre-washed and the packaging advises consumers not to
wash the salt, habits can be hard to break, and some people
probably still wash the Bon Sel. Tests on the effect of hand rinsing
(,5 seconds swirling in a bowl of water, or a similar time under a
stream of water) showed retention of 40–50% of the DEC citrate
and 60–70% of the iodate after the medicated salt was washed.
This result suggests that a fortification level of 0.3–0.4% DEC
citrate, at the high end of the recommended scale, would be likely
to deliver therapeutically useful doses to consumers of the
medicated salt regardless of whether or not they rinse it.
Conclusions
A simple titration-based assay allows determination of diethyl-
carbamazine (DEC) citrate concentrations in medicated salt
produced in Haiti for an anti-lymphatic filariasis program. The
assay can be carried out with widely available equipment and
materials and thus offers a useful tool for quality control and field
analysis of DEC. The development of this method, which allows
quantification of the medication, DEC citrate, has already proven
useful for quality control in the Haiti plant where salt fortification
takes place. Historically, identification and communication of
flaws in the salt fortification levels have taken several months as
samples were sent back to the US for analysis. Using the back
titration analysis of DEC, chemists in Haiti can now identify
variation in DEC loading as batches of Bon Sel are produced. This
analysis will allow the Bon Sel plant to act more rapidly and
independently in their effort to supply the area with properly
medicated salt. An increased efficiency in Bon Sel production
should bolster the endeavor to reduce and eventually eliminate
lymphatic filariasis in Haiti.
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